RE:RE:RE:Science always Wins!Iscfa,
if what you are saying is true, that the doctors at those 5 sites did not follow protocol adequately and this was the cause of this mess and FDA concurs with these findings and audits and if Trilogy 2 results will achieve the secondary end points (despite the screw-up pf those 5 labs which was no fault of Acasti), it would be a good.
========================================================================
The design protocols are not flawed. A few dopey doctors did not follow them. e.g. start a patient on a statin and register them in the trial before 6 weeks of stabilization on the statin. WalkOverTheStrt wrote:If the design protocols were flawed then it will not be kept mainly to the five sites in T2. In fact it could be worse... we just don't know. The fact the company's MC is $55m is unreal for a drug that works....